Clinical Trial Update: Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating armodafinil as adjunctive treatment for major depression in adults with Bipolar I Disorder; trial completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Bipolar I Depression | Phase 2 | Status: COMPLETED | Results posted: 2010-12-20